Charles R. Allerson

1 Patent

• US120051202024

  Galnac Conjugated Modified Oligonucleotides as Mir-122 Inhibitor Having HCV Antiviral Activity with Reduced Hyperbilirubinemia Side-effect

  Regulus Therapeutics Inc.

  0 cites